These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 32959529)
1. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy. Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529 [TBL] [Abstract][Full Text] [Related]
2. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128 [TBL] [Abstract][Full Text] [Related]
3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
4. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC. Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338 [TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks. Zhao X; Bai Z; Li C; Sheng C; Li H Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578 [TBL] [Abstract][Full Text] [Related]
6. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma. Wang S; Bai H; Fei S; Miao B Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914 [TBL] [Abstract][Full Text] [Related]
7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
8. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC. Wang W; Wang L; Song C; Mu T; Hu J; Feng H J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients. Bai Z; Li H; Li C; Sheng C; Zhao X Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
12. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma. Fu P; Gong B; Li H; Luo Q; Huang Z; Shan R; Li J; Yan S Int J Cancer; 2022 Nov; 151(10):1824-1834. PubMed ID: 35802466 [TBL] [Abstract][Full Text] [Related]
13. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma. Zhang X; Li W; Li S; Zhang Z; Song W Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442 [TBL] [Abstract][Full Text] [Related]
14. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related]
15. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients. Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106 [TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma. Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma. Gong X; Wei W; Chen L; Xia Z; Yu C Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756 [TBL] [Abstract][Full Text] [Related]
18. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature. Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988 [TBL] [Abstract][Full Text] [Related]
20. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma. Fang Q; Chen H Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]